Paper
0
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
Authors
Zefei Jiang,Wei Li
Xichun Hu,Qingyuan Zhang,Tao Sun,Shude Cui,Shusen Wang,Quchang Ouyang,Yongmei Yin,Cuizhi Geng,Zhongsheng Tong,Ying Cheng,Yueyin Pan,Yuping Sun,Hong Wang,Tao Ouyang,Kangsheng Gu,Jifeng Feng,Xiaojia Wang,Shubin Wang,Tianshu Liu,Jinghua Gao,Massimo Cristofanilli,Zhiqiang Ning
+22 authors
,Xianping LuJournal
Published
Apr 27, 2019
Show more
Save
Tip0
TipSave